Evidence map›Paper›PMID 39992493›Full record

ArticleCell and tissue banking2025

Struggling with a cefazolin impregnation protocol of bone chips.

K Dendoncker, G Putzeys, T Nieuwenhuizen, P Voet, S Lambrecht, M Bertrand, H Valster, K Croes

Abstract read
In one paragraph

Article in Cell and tissue banking, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Study of the release kinetics of dalbavancin from bone allografts.Journal of materials science. Materials in medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

K DendonckerBone Bank, Az Groeninge, President Kennedylaan 4, 8500, Kortrijk, Belgium. karen.dendoncker@azgroeninge.be.
G PutzeysBone Bank, Az Groeninge, President Kennedylaan 4, 8500, Kortrijk, Belgium.
T NieuwenhuizenClinical Laboratory, Az Groeninge, Kortrijk, Belgium.
P VoetClinical Laboratory, Az Groeninge, Kortrijk, Belgium.
S LambrechtDepartment of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium.
M BertrandHCM Medical, Nijmegen, The Netherlands.
H ValsterHCM Medical, Nijmegen, The Netherlands.
K CroesClinical Laboratory, Az Groeninge, Kortrijk, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotics released locally through a carrier is a commonly used technique to prevent infection in orthopaedic procedures. Antibiotic-impregnated bone chips are an interesting carrier in bone reconstructive surgery. Cefazolin is a potentially interesting antibiotic given its proven efficiency in preventing surgical site infection when administered systemically. Preliminary in vitro studies with fresh frozen or processed bone chips impregnated with cefazolin solution showed rapid complete release within a few hours, questioning its potential for local infection prophylaxis. On the other hand, commercially available bone chips impregnated after purification using supercritical CO

Indexed as

Anti-Bacterial AgentsBone and BonesCefazolinHumansSurgical Wound InfectionAnti-Bacterial AgentsCefazolinBone allograftCefazolinImpregnationLocal antibiotic releaseSupercritical CO2Vancomycin

Identifiers

PMID39992493
PMCPMC11850557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.